Single-use Assemblies Market with Highest growth in the near future by leading key players
Global Single-Use Assemblies Market
Overview
The Global Single-Use
Assemblies Market, valued at USD 2.25 billion, is projected to
expand at a robust CAGR of 22% through 2026. Market growth is driven by
the increasing adoption of ready-to-use single-use assemblies, strong funding
support for the development of single-use technologies, the expanding biologics
and vaccines market, and rising investments in biopharmaceutical R&D.
Single-use assemblies are custom-engineered,
ready-to-use systems composed of multiple plastic components configured
into a unified, sterile solution based on specific process requirements. These
assemblies play a crucial role in modern bioprocessing, offering flexibility,
sterility, and operational efficiency compared to traditional stainless-steel
systems.
Download Sample Copy: https://meditechinsights.com/single-use-assemblies-market/request-sample/
Key Advantages Driving Market Growth
Traditionally, bioprocessing end users have
performed in-house assembly of single-use systems, which often increases the
risk of improper connections, leakage, and cross-contamination—leading to
costly production delays. In contrast, pre-assembled single-use systems
mitigate these risks by providing standardized, sterile, and quality-controlled
solutions.
Major advantages of single-use assemblies
include:
- Faster integration of single-use components within bioprocess
workflows
- Lower risk of contamination and system leakage
- Reduced labor, material, and operational costs
- Elimination of cleaning requirements and downtime
- Significant savings in water and energy consumption
- Improved documentation and quality control
- Enhanced overall process efficiency
Growing Funding Support Accelerates
Market Expansion
The increasing preference for disposable
and flexible production systems has led nearly every sterile manufacturing
segment to transition toward single-use alternatives. These systems
substantially reduce facility setup and cleaning costs, minimize batch
contamination risks, and enhance production agility—key benefits driving
widespread adoption.
Governmental and institutional funding
initiatives are further boosting production capabilities across the sector.
Notable examples include:
- High Purity New England received a USD
15 million grant (January 2022) from the Biomedical Advanced
Research and Development Authority (BARDA) to expand production of
single-use assemblies, pumps, and sterile packaged components.
- Meissner Filtration Products
secured a USD 13.4 million BARDA contract (April 2021) to
accelerate the manufacturing capacity of single-use systems vital for
COVID-19 vaccine and therapeutic production.
“Single-use assemblies deliver everything
bioprocessors need—from bags and connectors to filters and tubing—enabling
flexible and scalable manufacturing for a wide range of therapies. They are
essential to the global vaccine and biologics supply chain.”
— Senior Director, Leading Single-use Assembly Manufacturer, United States
Market Challenge: Risk of Leachables
Despite their advantages, leachables remain
a key concern in the use of single-use systems. These are chemical compounds
that may migrate from plastic or elastomeric components into drug formulations
during processing or storage. The presence of leachables can compromise drug
purity, product quality, and patient safety.
To address this challenge, industry
stakeholders are implementing:
- Comprehensive extractables and leachables studies
- Risk-based assessments and toxicological evaluations
- Adoption of standardized characterization protocols
- Collaborative guidance development between suppliers and end
users
Such proactive measures are expected to
mitigate contamination risks and sustain the long-term adoption of single-use
technologies across the biopharmaceutical sector.
Competitive Landscape
The global single-use assemblies market is
characterized by the presence of several established players competing through
technological innovation, capacity expansion, and strategic partnerships.
Leading companies include:
- Thermo Fisher Scientific, Inc.
- Sartorius Stedim Biotech
- Danaher Corporation
- Merck KGaA
- Avantor, Inc.
- Saint-Gobain
- and other emerging regional manufacturers.
Order Now: https://meditechinsights.com/purchase/single-use-assemblies-market/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused
business research & insights firm. Our clients include Fortune 500
companies, blue-chip investors & hyper-growth start-ups. We have completed
100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical
Devices & Pharma Services in the areas of market assessments, due
diligence, competitive intelligence, market sizing and forecasting, pricing
analysis & go-to-market strategy. Our methodology includes rigorous
secondary research combined with deep-dive interviews with industry-leading
CXO, VPs, and key demand/supply side decision-makers.
Comments
Post a Comment